GL
BMY icon

GLG LLC’s Bristol-Myers Squibb BMY Stock Holding History

GLG LLC’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-89,500
Closed -$4.99M – 504
2017
Q2 		$4.99M Sell
89,500
-10,500
-11% -$571K 0.31% 95
2017
Q1 		$5.44M Buy
+100,000
New +$5.48M 0.3% 92
2015
Q1 		– Sell
-479,700
Closed -$28.3M – 621
2014
Q4 		$28.3M Sell
479,700
-20,300
-4% -$1.14M 0.85% 17
2014
Q3 		$25.6M Buy
+500,000
New +$25M 0.68% 23

Other funds holding BMY

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

GLG LLC's BMY Position: Q4 2017 in Review

GLG LLC held its Bristol-Myers Squibb (BMY) position steady in Q4 2017 at 169,273 shares worth $10.4M. The position accounts for 0.74% of the portfolio, ranked #30.

GLG LLC first reported a position in BMY in Q1 2014 and has held it in 16 quarters since. The position peaked at $24.6M in Q3 2014. 1,735 funds tracked by Wall St. Rank hold BMY as of Q4 2017.

  • GLG LLC held 169,273 shares of Bristol-Myers Squibb worth $10.4M as of Q4 2017.
  • GLG LLC left its Bristol-Myers Squibb share count unchanged in Q4 2017.
  • Bristol-Myers Squibb made up 0.74% of GLG LLC's portfolio in Q4 2017, its #30 holding.
  • GLG LLC first reported a position in Bristol-Myers Squibb in Q1 2014 and has held it in 16 quarters since.
  • GLG LLC's Bristol-Myers Squibb position peaked at $24.6M in Q3 2014.
  • 1,735 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2017.

Based on GLG LLC's 13F filing for Q4 2017, filed 14 Feb 2018.